In a letter to members, Dr. Susan Froshauer, president and CEO of CURE, points to some recent benchmarks CURE has achieved.

“This is an exciting time for Connecticut bioscience and CURE is playing an instrumental role,” Dr. Froshauer says. “As an important driver of our state’s life and healthcare science community, we are actively broadening our impact into areas essential for the continued expansion of Connecticut’s bioscience sector.”